Jonathan Moens is a former intern at Spectrum and a graduate student at New York University’s Science, Health and Environmental Reporting Program. He studied philosophy and neuroscience as an undergraduate student at University College London in the United Kingdom. He received an M.Sc. in brain and mind sciences at University College London and École Normale Supérieure in Paris, France, specializing in cognitive neuroscience. He previously worked as a research assistant at the Neurospin laboratory in Paris and the Center for the Neuroscience of the Senses in London.
Jonathan Moens
From this contributor
Autism comorbidities reflect racial, ethnic disparities
Autistic people from historically marginalized races and ethnicities are more likely than their white peers to be diagnosed with accompanying health conditions.
Autism comorbidities reflect racial, ethnic disparities
By
Jonathan Moens
19 January 2022 | 2 min read
By the Numbers: Autism in translation, rising prevalence figures, intelligence quotients
In this edition of By the Numbers, we discuss how translation alters a screening tool’s accuracy, the closing racial gap in autism prevalence numbers, and the preponderance of autism without intellectual disability.
By the Numbers: Autism in translation, rising prevalence figures, intelligence quotients
By
Peter Hess, Niko McCarty, Jonathan Moens
21 December 2021 | 1 min read
Autism without intellectual impairments more common than previously reported
Almost 60 percent of autistic people may have an average or above-average intelligence quotient, according to a new longitudinal study.
Autism without intellectual impairments more common than previously reported
By
Jonathan Moens
1 December 2021 | 2 min read
Rethinking autism assessments in the time of COVID-19: Q&A with Bishop, Zwaigenbaum
Moving most clinical assessments online during the coronavirus pandemic has created a digital divide while closing some geographical ones, say Somer Bishop and Lonnie Zwaigenbaum.
Rethinking autism assessments in the time of COVID-19: Q&A with Bishop, Zwaigenbaum
By
Jonathan Moens
2 November 2021 | 7 min read
Disruptions to brain’s ‘thermostat’ may underpin autism traits
Mounting evidence suggests that autism often involves upsets in homeostatic plasticity, a set of processes neurons use to stabilize their activity. These disruptions result from a range of autism-linked mutations and may help to explain the condition’s famed heterogeneity.
Disruptions to brain’s ‘thermostat’ may underpin autism traits
By
Jonathan Moens
18 August 2021 | 7 min read
Explore more from The Transmitter
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
‘Tour de force’ study flags fount of interneurons in human brain
The newly discovered cell type might point to the origins of the inhibitory imbalance linked to autism and other conditions.
By
Holly Barker
29 January 2026 | 4 min read
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
By
Paul Middlebrooks
28 January 2026 | 1 min read
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read